Biomas Ltd.
Records under this name other than patents Biomas Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,011,933 | Therapeutic methods and pharmaceutical compositions for treating warts with tellurium compounds Formerly held In force · High confidence | In force | High confidence | |
| US 9,700,536 | Topical formulations of tellurium-containing compounds Formerly held Lapsed on the fee record Ended Jul 11, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jul 11, 2025 | From the USPTO record |
| US 9,216,197 | Topical formulations of tellurium-containing compounds Formerly held Lapsed on the fee record Ended Dec 22, 2023 · From the USPTO record | Lapsed on the fee record | Ended Dec 22, 2023 | From the USPTO record |
| US 8,703,753 | Use of tellurium compounds for the treatment of actinic keratosis Formerly held Lapsed on the fee record Ended Apr 22, 2022 · From the USPTO record | Lapsed on the fee record | Ended Apr 22, 2022 | From the USPTO record |
| US 7,652,065 | Tellurium compounds and their use as immunomodulators Formerly held Lapsed on the fee record Ended Jan 26, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jan 26, 2022 | From the USPTO record |
| US 8,623,908 | Use of tellurium compounds for inhibition of interleukin-converting enzyme Formerly held Lapsed on the fee record Ended Jan 7, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jan 7, 2022 | From the USPTO record |
| US 6,472,381 | Method of treating psoriasis Formerly held Term ended Term ended Oct 12, 2021 · From the USPTO record | Term ended | Term ended Oct 12, 2021 | From the USPTO record |
| US 8,048,915 | Biologically Active Complex Formerly held Lapsed on the fee record Ended Nov 1, 2019 · Medium confidence | Lapsed on the fee record | Ended Nov 1, 2019 | Medium confidence |
| US 7,276,628 | Biologically Active Complex Formerly held Lapsed on the fee record Ended Oct 2, 2019 · High confidence | Lapsed on the fee record | Ended Oct 2, 2019 | High confidence |
| US 7,709,524 | Use of tellurium compounds for inhibition of interleukin-converting enzyme Formerly held Lapsed on the fee record Ended May 4, 2018 · From the USPTO record | Lapsed on the fee record | Ended May 4, 2018 | From the USPTO record |